Sensilia Laboratory is a French, family-owned and independent laboratory based in Gironde, France. Since 2019, we have been researching and manufacturing healthy, innovative wellness products.
Need help?
+33 5 54 54 00 79
support@sensilia.com
Secure payments on sensilia.com with
Made by Fifty Seven & Ocean Vert Distribution
Sensilia/Pernixol® all rights reserved
Omega-3 for Dogs: The Complete Guide
Discover how Omega-3 support your dog's joints, skin and brain with effective sources, appropriate dosages and the science to back it up.
Omega-3 are far more than a simple nutritional trend; they constitute a fundamental building block for the well-being and longevity of our canine companions. Recognised for their ability to modulate inflammation and support vital functions, these essential fatty acids have become indispensable in animal nutrition.
Discover the science behind Omega-3 and how to optimise intake for your dog's joint, cognitive and skin health.
What are Omega-3?
Omega-3 belong to the family of polyunsaturated fatty acids. They are classed as essential because dogs — like humans — cannot produce them in adequate amounts. They must therefore be supplied through food or supplementation.
A fatty acid is a basic component of fats. Omega-3 are called 'polyunsaturated' due to their chemical structure, which makes them particularly flexible and useful for cell membranes.
Within this family, three fatty acids are at the centre of scientific interest:
ALA (Alpha-Linolenic Acid): It is the precursor, mainly found in plant-based sources (flaxseed, hemp, walnuts).
EPA (Eicosapentaenoic Acid): Mainly derived from marine organisms (algae, fish, crustaceans). It is the conductor of anti-inflammatory regulation (Bauer, 2007).
DHA (Docosahexaenoic Acid): Also of marine origin, it is essential for the development and structure of the nervous system, retina and cell membranes, and for cartilage protection (Bauer, 2011).
In dogs, the ability to convert ALA into EPA and DHA is very limited, less than 10% (National Research Council, 2006). This is why, to guarantee biological efficacy, it is crucial to prioritise direct sources of EPA and DHA.
Mechanism of Action of Omega-3
The efficacy of Omega-3 rests on their ability to integrate into the membranes of every cell, thereby helping the body to function better at its most fundamental level.
Omega-6 / Omega-3 Balance
Standard commercial dog food is often unbalanced, largely favouring the intake of Omega-6 (derived from vegetable oils such as corn or sunflower). These Omega-6 are precursors to pro-inflammatory molecules (such as series 2 prostaglandins and leukotriene B4).
The Omega-6/Omega-3 Balance: Omega-6 are necessary, but in excess they serve as 'fuel' for inflammation. An imbalance therefore promotes a state of chronic inflammation (Wander et al., 1997).
When EPA is available in sufficient quantities, it competes with these Omega-6. It takes their place in cell membranes and in enzymatic reactions (biochemical processes driven by enzymes), leading to the [REDACTED] of mediators that are less aggressive to tissues (McPhee et al., 2007; Treschow et al., 2007).
Regulation of Inflammation and Joint Protection
EPA and DHA don't just slow inflammation — they actively resolve it.
Action on Enzymes: EPA modulates the activity of COX and LOX enzymes, reducing the [REDACTED] of painful and swelling mediators in the joint (Mehler et al., 2016; Adler et al., 2018). These enzymes (Cyclooxygenases and Lipoxygenases) are biological accelerators that transform fats into inflammation signals. Omega-3 act as a natural 'brake' on these processes.
Resolvins, Protectins and Homeostasis: EPA and DHA are the precursors to a class of 'pro-resolving' molecules: resolvins and protectins. These compounds act as biological cleaning agents, helping the dog's body to extinguish inflammation and restore tissue balance (homeostasis) (Calder, 2015).
Cellular Protection: DHA, in particular, contributes to stabilising subchondral bone by regulating the activity of osteoclasts (cells responsible for bone resorption), thus playing an essential chondroprotective role for articular cartilage. Osteoclasts are cells that 'erode' bone. DHA regulates them to protect the bone beneath the cartilage. The 'chondroprotective' role means that it directly protects cartilage cells (Rahman et al., 2008; Ma et al., 2023; Wang et al., 2016).
Omega-3, and especially EPA and DHA, are the best-documented active ingredients in canine nutrition for a variety of indications:
Mobility and Joint Comfort
In 2022, researchers from the Faculty of Veterinary Medicine of Montreal published a systematic review of available clinical studies on dietary supplements for arthritic dogs and cats (Barbeau-Grégoire et al., 2022) and demonstrated that Omega-3 were the most effective.
Omega-3 are the most effective and best-documented active ingredients clinically, far ahead of other widely marketed ingredients such as glucosamine, collagen or plant extracts.
Barbeau-Grégoire
Improved mobility: Clinical studies show a reduction in lameness and improved ability to bear weight on the limb (Roush et al., 2010; Moreau et al., 2013).
Pain relief: Reduction in joint stiffness and potentially a decreased need for non-steroidal anti-inflammatory drugs (NSAIDs) (Mehler et al., 2016; Fritsch et al., 2010).
Tissue preservation: Protection of cartilage against chronic enzymatic degradation (Hansen et al., 2008).
Thanks to their anti-inflammatory action, Omega-3 are a major asset for pruritic or atopic dermatitis:
Strengthening of the skin barrier.
Reduction of itching (pruritus) and alopecia related to self-mutilation (Magalhães et al., 2021).
Improvement of coat quality: shinier and denser.
Brain Function and Cognitive Development
DHA is a major constituent of neuronal membranes (the envelope of nerve cells). Its supply is essential:
In puppies: It supports neurological development, learning and motor skills (Rodrigues et al., 2023).
In senior dogs: It helps to preserve cognitive function and neuronal plasticity (the brain's ability to form new connections essential to memory and learning) in the face of ageing (Bauer, 2011).
Cardiovascular Support
Omega-3 contribute to the regulation of the cardiovascular system, notably helping to maintain a balanced blood pressure and playing a role in triglyceride levels (Smith et al., 2007; Nasciutti et al., 2021).
The Best Sources of Omega-3
Not all sources of Omega-3 are equal, especially when it comes to guaranteeing the purity of EPA and DHA and respect for the environment.
Plant-based Sources
Flaxseed, rapeseed or hemp oils are rich in ALA, but this precursor is poorly converted to EPA and DHA in dogs. They are valuable for their healthy fat content, but cannot effectively correct an active Omega-3 deficiency.
Classic Marine Sources
Oily Fish (Fish Oils): Historically rich in EPA and DHA (sardine, anchovy, mackerel). However, they are subject to the progressive accumulation of toxic substances in the body (heavy metals, PCBs) and are often linked to problems of overfishing and the decline of their own Omega-3 content (Lloret et al., 2025; Sprague et al., 2016).
Antarctic Krill: Provides Omega-3 in phospholipid form, which is very well absorbed. Nevertheless, krill is a keystone species of the Antarctic food chain, and its mass exploitation weakens the marine ecosystem (Meyer et al., 2025; Zhang et al., 2025).
Sustainable Marine Sources
The best sources combine a richness in active Omega-3 (EPA/DHA) with impeccable traceability:
Microalgae Oil: They are the primary source of marine Omega-3. Cultivated in fermenters, they produce high-purity DHA, with no risk of heavy metals and without impacting the oceans. They represent a sustainable and ultra-pure alternative to fish oils.
New Zealand Green Lipped Mussel Oil(Perna canaliculus): This source is unique. Its cultivation is strictly regulated and environmentally responsible. It provides not only EPA and DHA, but also rare Omega-3, such as ETA (Eicosatetraenoic Acid), known for its specific action on the LOX enzyme, reinforcing the overall anti-inflammatory effect. Its efficacy on mobility is clinically demonstrated in dogs.
The dose of Omega-3 (total EPA + DHA) is the key factor of efficacy. Dosage must be adjusted according to the objective and may be defined with veterinary guidance if necessary.
At this stage, there are no dosages recommended by French or European authorities for dogs. However, one can rely on the dosages judged effective in the scientific literature:
Omega-3 Dosage
Condition
Effective EPA + DHA Dose
Minimum Duration
Observed Clinical Effects
Severe Joint Disorders
60-100 mg/kg/jour
6 à 12 weeks
Reduced pain and stiffness, improved mobility
Allergic Dermatitis
50-90 mg/kg/jour
8 à 10 weeks
Reduced itching, erythema, and secondary skin lesions
Dull Coat / Poor Coat Condition
EPA : 16 mg/kg DHA : 10 mg/kg
3 months
Improved seborrheic index and coat quality
Joint Health Maintenance & Prevention
14 mg/kg/ jour EPA+DHA
Continuous
Maintains joint flexibility and improves mobility during exercise
Even without apparent joint symptoms, a moderate Omega-3 supplementation can help maintain joint flexibility, support the immune system and preserve skin and coat quality.
In healthy adult dogs, a daily intake of 14 mg of EPA+DHA per kilogram of body weight is recommended.
National Research Council
To make daily dosing easier, here is a reference guide by dog size:
Choosing a dosage tailored to your dog's weight
Tranche de poids
Poids moyen
Dosage quotidien recommandé (EPA+DHA)
Moins de 10 kg
7 kg
98 mg/jour
10 à 20 kg
15 kg
210 mg/jour
20 à 30 kg
30 kg
420 mg/jour
Plus de 40 kg
45 kg
630 mg/jour
These intakes can be provided by enriched food or by a supplement containing a quality Omega-3 source (such as green lipped mussel oil or algae), well tolerated over the long term. They help maintain the mechanisms that regulate inflammation and support healthy ageing.
Choosing the Right Omega-3 Supplement for Your Dog
The choice of a supplement should not be based solely on price, but on criteria of quality, stability and bioavailability (the body's ability to absorb ingested nutrients).
Concentration and Clinical Efficacy
An Omega-3 supplement is only effective if the active forms (EPA and DHA) are present in sufficient quantities and in a form that has demonstrated its benefit.
Check the active ingredients: Only marine Omega-3 (EPA, DHA) have a proven clinical effect on inflammation and mobility (Barbeau-Grégoire et al., 2022). Plant-based Omega-3 (ALA) are too poorly converted in dogs.
Watch the concentration: Avoid products displaying well-known ingredients at token doses. Efficacy depends on achieving the dosages recommended by science.
Prefer the liquid form: The oily liquid form is the most suitable for Omega-3, as it offers better absorption and superior digestive tolerance compared to powders or chews (which are often underdosed).
The quality of an Omega-3 oil is determined by its freshness and purity, which guarantee its long-term efficacy.
Stability and Oxidation: The oil must be non-oxidised. Oxidation,measured by the TOTOX index, makes the oil rancid and ineffective. A TOTOX index below 26 is an essential quality guarantee. It is a key laboratory indicator to ensure that the oil is fresh and pure — meaning it has not gone rancid on contact with air.
Contaminant Testing: A serious laboratory must provide release analyses confirming that environmental pollutants (heavy metals, dioxins, PCBs) are absent or within safe limits — especially critical for marine sources susceptible to bioaccumulation.
Traceability and Extraction: Demand full transparency on the origin of raw materials (fishing/farming zone, cultivation method) and the extraction process used (prefer gentle, solvent-free methods).
Choosing PERNIXOL® means putting an end to compromise. After analysing the science and the pitfalls of under-dosed or clinically unproven supplements, we formulated the solution every owner demands: the perfect alliance of efficacy, quality and naturalness.
PERNIXOL® is not just a supplement, it is a commitment to your dog's future.
Our secret lies in a unique synergy of premium, ultra-concentrated, stable and traceable marine actives:
New Zealand Green Lipped Mussel Oil (Perna canaliculus) :Farmed in the protected ocean zones of the Marlborough Sounds, it provides not only the essential EPA and DHA, but also the rare Omega-3 ETA for unparalleled anti-inflammatory action. It is the flagship ingredient for canine mobility.
Ultra-Pure Microalgae Oil (Schizochytrium sp.): Our highest-concentration DHA source. Fermentation-grown for guaranteed absolute purity (zero contaminants), it actively protects your dog's cartilage.
Manufactured in our laboratory in St-Jean-d'Illac, France (Gironde), PERNIXOL®is the only liquid formula rich in sustainable Omega-3for your dog's joint health.
Easy to dose and with a taste dogs love, PERNIXOL®gives your dog back the freedom to run, play and share every moment by your side without restraint.
Omega-3 are essential to the lasting health of your dog. This guide has demonstrated that not all Omega-3 are equal: only EPA and DHA, derived from pure and traceable marine sources, have the power to modulate inflammation and protect joints and the brain. Efficacy does not depend on chance, but on adherence to precise dosing and impeccable quality (low TOTOX, optimal concentration).
Key Takeaways
EPA and DHA are the most effective Omega-3 for dogs.
They support joints, skin and the brain.
Marine sources are more effective than plant-based sources.
Quality depends on purity, dosage and stability.
Regular supplementation helps preserve mobility and vitality.
By choosing a supplement such as PERNIXOL®, you are opting for science in the service of well-being, guaranteeing your companion the optimal intake to regain suppleness and vitality.
Bauer JE. The essential nature of dietary omega-3 fatty acids in dogs. J Am Vet Med Assoc. 2016 Dec 1;249(11):1267-1272. doi: 10.2460/javma.249.11.1267. PMID: 27875089.
Bauer JE. Therapeutic use of fish oils in companion animals. J Am Vet Med Assoc. 2011 Dec 1;239(11):1441-51. doi: 10.2460/javma.239.11.1441. PMID: 22087720.
Bauer JE. Responses of dogs to dietary omega-3 fatty acids. J Am Vet Med Assoc. 2007 Dec 1;231(11):1657-61. doi: 10.2460/javma.231.11.1657. PMID: 18052798.
National Research Council (NRC). (2006). Nutrient Requirements of Dogs and Cats. The National Academies Press.
Wander RC, Hall JA, Gradin JL, Du SH, Jewell DE. The ratio of dietary (n-6) to (n-3) fatty acids influences immune system function, eicosanoid metabolism, lipid peroxidation and vitamin E status in aged dogs. J Nutr. 1997 Jun;127(6):1198-205. doi: 10.1093/jn/127.6.1198. PMID: 9187636.
McPhee S, Hodges LD, Wright PF, Wynne PM, Kalafatis N, Harney DW, Macrides TA. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol. 2007 Mar;146(3):346-56. doi: 10.1016/j.cbpb.2006.11.001. Epub 2006 Nov 17. PMID: 17197217.
Treschow AP, Hodges LD, Wright PF, Wynne PM, Kalafatis N, Macrides TA. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol. 2007 Aug;147(4):645-56. doi: 10.1016/j.cbpb.2007.04.004. Epub 2007 Apr 14. PMID: 17543561.
Mehler SJ, May LR, King C, Harris WS, Shah Z. . Prostaglandins Leukot Essent Fatty Acids. 2016 Jun;109:1-7. doi: 10.1016/j.plefa.2016.03.015. Epub 2016 Mar 30. PMID: 27269707.
This guide was written by the R&D team at Laboratoire Sensilia, experts in animal nutrition.
A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis
Adler N, Schoeniger A, Fuhrmann H. Polyunsaturated fatty acids influence inflammatory markers in a cellular model for canine osteoarthritis. J Anim Physiol Anim Nutr (Berl). 2018 Apr;102(2):e623-e632. doi: 10.1111/jpn.12804. Epub 2017 Oct 13. PMID: 29030883.
Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015 Apr;1851(4):469-84. doi: 10.1016/j.bbalip.2014.08.010. Epub 2014 Aug 20. PMID: 25149823.
Rahman MM, Bhattacharya A, Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J Cell Physiol. 2008 Jan;214(1):201-9. doi: 10.1002/jcp.21188. PMID: 17929247.
Ma J, Kitaura H, Ogawa S, Ohori F, Noguchi T, Marahleh A, Nara Y, Pramusita A, Kinjo R, Kanou K, Kishikawa A, Ichimura A, Mizoguchi I. Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120. Front Immunol. 2023 Jan 18;13:929690. doi: 10.3389/fimmu.2022.929690. PMID: 36741381; PMCID: PMC9889988.
Wang Z, Guo A, Ma L, Yu H, Zhang L, Meng H, Cui Y, Yu F, Yang B. Docosahexenoic acid treatment ameliorates cartilage degeneration via a p38 MAPK-dependent mechanism. Int J Mol Med. 2016 Jun;37(6):1542-50. doi: 10.3892/ijmm.2016.2567. Epub 2016 Apr 14. PMID: 27082436; PMCID: PMC4866951.
Roush JK, Cross AR, Renberg WC, Dodd CE, Sixby KA, Fritsch DA, Allen TA, Jewell DE, Richardson DC, Leventhal PS, Hahn KA. Evaluation of the effects of dietary supplementation with fish oil omega-3 fatty acids on weight bearing in dogs with osteoarthritis. J Am Vet Med Assoc. 2010 Jan 1;236(1):67-73. doi: 10.2460/javma.236.1.67. PMID: 20043801.
Moreau M, Troncy E, Del Castillo JR, Bédard C, Gauvin D, Lussier B. Effects of feeding a high omega-3 fatty acids diet in dogs with naturally occurring osteoarthritis. J Anim Physiol Anim Nutr (Berl). 2013 Oct;97(5):830-7. doi: 10.1111/j.1439-0396.2012.01325.x. Epub 2012 Jul 14. PMID: 22805303.
Fritsch D, Allen TA, Dodd CE, Jewell DE, Sixby KA, Leventhal PS, Hahn KA. Dose-titration effects of fish oil in osteoarthritic dogs. J Vet Intern Med. 2010 Sep-Oct;24(5):1020-6. doi: 10.1111/j.1939-1676.2010.0572.x. Epub 2010 Aug 12. Erratum in: J Vet Intern Med. 2011 Jan-Feb;25(1):167. PMID: 20707845.
Hansen RA, Harris MA, Pluhar GE, Motta T, Brevard S, Ogilvie GK, Fettman MJ, Allen KG. Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease. J Nutr Biochem. 2008 Feb;19(2):101-8. doi: 10.1016/j.jnutbio.2007.01.008. Epub 2007 May 24. PMID: 17531456.
Magalhães TR, Lourenço AL, Gregório H, Queiroga FL. Therapeutic Effect of EPA/DHA Supplementation in Neoplastic and Non-neoplastic Companion Animal Diseases: A Systematic Review. In Vivo. 2021 May-Jun;35(3):1419-1436. doi: 10.21873/invivo.12394. Epub 2021 Apr 28. PMID: 33910819; PMCID: PMC8193331.
Rodrigues RBA, Zafalon RVA, Rentas MF, Risolia LW, Macedo HT, Perini MP, Silva AMGD, Marchi PH, Balieiro JCC, Mendes WS, Vendramini THA, Brunetto MA. The Supplementation of Docosahexaenoic Acid-Concentrated Fish Oil Enhances Cognitive Function in Puppies. Animals (Basel). 2023 Sep 16;13(18):2938. doi: 10.3390/ani13182938. PMID: 37760338; PMCID: PMC10525578.
Smith CE, Freeman LM, Rush JE, Cunningham SM, Biourge V. Omega-3 fatty acids in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J Vet Intern Med. 2007 Mar-Apr;21(2):265-73. doi: 10.1892/0891-6640(2007)21[265:ofaibd]2.0.co;2. PMID: 17427387.
Nasciutti PR, Moraes AT, Santos TK, Gonçalves Queiroz KK, Costa APA, Amaral AR, Fernando Gomes Olivindo R, Pontieri CFF, Jeremias JT, Vendramini THA, Brunetto MA, Carvalho ROA. Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C. PLoS One. 2021 Jul 15;16(7):e0254887. doi: 10.1371/journal.pone.0254887. PMID: 34265016; PMCID: PMC8282066.
Lloret, Josep & Vila Belmonte, Mar & Izquierdo, Angel & San, Joan & Porsmoguer, Sebastián. (2025). The unsustainability of the Omega-3 supply from seafood in the Mediterranean under global change. Food Policy. 136. 1-12. 10.1016/j.foodpol.2025.102972.
Sprague M, Dick JR, Tocher DR. Impact of sustainable feeds on omega-3 long-chain fatty acid levels in farmed Atlantic salmon, 2006-2015. Sci Rep. 2016 Feb 22;6:21892. doi: 10.1038/srep21892. PMID: 26899924; PMCID: PMC4761991.
Meyer, B. , Arata, J. A. , Atkinson, A. , Bahlburg, D. , Bernard, K. , Cárdenas, C. A. , Grant, S. M. , Hill, S. L. , Hüppe, L. , Ichii, T. , Kawaguchi, S. , Krafft, B. A. , Labrousse, S. , Maschette, D. , Piñones, A. , Reiss, C. , Siebenhüner, B. , Sylvester, Z. and Ziegler, P. (2025), Adjusting the management of the Antarctic krill fishery to meet the challenges of the 21st century, Proceedings of the National Academy of Sciences of the United States of America, 122 (37), e2412624122-e2412624122 . doi: 10.1073/pnas.2412624122
Zhang, Haiyan & Ji, Yunyun & Jiang, Zhongquan & Yang, Guangxin & Kong, Cong & Shen, Zhemin & Yuan, Tao & Shen, Xiaosheng. (2025). Arsenic toxicity in Antarctic krill oil and its impact on human intestinal cells. Ecotoxicology and Environmental Safety. 289. 117680. 10.1016/j.ecoenv.2025.117680.
Burri L, Hoem N, Banni S, Berge K. Marine omega-3 phospholipids: metabolism and biological activities. Int J Mol Sci. 2012 Nov 21;13(11):15401-19. doi: 10.3390/ijms131115401. PMID: 23203133; PMCID: PMC3509649.
Pollard B, Guilford WG, Ankenbauer-Perkins KL, Hedderley D. Clinical efficacy and tolerance of an extract of green-lipped mussel (Perna canaliculus) in dogs presumptively diagnosed with degenerative joint disease. N Z Vet J. 2006 Jun;54(3):114-8. doi: 10.1080/00480169.2006.36622. PMID: 16751841.
Vijarnsorn M, Kwananocha I, Kashemsant N, Jarudecha T, Lekcharoensuk C, Beale B, Peirone B, Lascelles BDX. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis. BMC Vet Res. 2019 Oct 17;15(1):349. doi: 10.1186/s12917-019-2110-7. Erratum in: BMC Vet Res. 2020 Dec 16;16(1):486. doi: 10.1186/s12917-020-02713-9. PMID: 31623621; PMCID: PMC6798752.
Kang K, Kim N, Lim S, Kang B. Therapeutic Effect of Green-Lipped Mussel Oil on Pain and Functional Disability in Dogs with Clinical Osteoarthritis. J Vet Clin 2024;41:350-358. https://doi.org/10.17555/jvc.2024.41.6.350
Barbeau-Grégoire M, Otis C, Cournoyer A, Moreau M, Lussier B, Troncy E. A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis. Int J Mol Sci. 2022 Sep 8;23(18):10384. doi: 10.3390/ijms231810384. PMID: 36142319; PMCID: PMC9499673.
